A generic version of Reckitt’s Nurofen Rapid 400mg soft capsules (ibuprofen) should have its marketing authorization suspended in multiple EU member states over safety concerns, the European Medicines Agency has recommended.
[Sidebar#GB153307]
EMA Urges Suspension Of Ibuprofen Generic Across Europe
Listen to this article
Ibuprofen generic sold by Spain's Liconsa should have its marketing authorization suspended in multiple EU member states as it is not bioequivalent to reference product Nurofen Rapid, rules the European Medicines Agency.
Stay ahead of every shift in generics and biosimilars.
More from Regulation
• By
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
• By
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
• By
Also, Latest News From Europe, Canada, Saudi Arabia, Finland, China, And The US
• By
Japanese generics giant Sawai appears to be turning a corner, but the impact of National Health Insurance pricing revisions continues to hold the firm – and the rest of the country’s generics industry – back.
More from Policy & Regulation
Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.
Emerging CRISPR innovations, shifting regulatory landscapes, and rising partnerships are accelerating a paradigm shift in biotech pipelines
After US President Joe Biden launched a review of the country’s API supply chain, the task force has reported back with key vulnerabilities that contribute to drug shortages and supply risks during a global public health emergency. According to the report, the lack of geographic diversity and dependence on foreign nations and anti-competitive actions by foreign nations are key areas of concern.